Titlebook: Cancer Diagnostics; Current and Future T Robert M. Nakamura,Wayne W. Grody,Raymond B. Nagle Book 2004 Springer Science+Business Media New Y

緩解

鴕鳥

CIS

嫻熟

F. Neuhuber,H. Brossmann,P. Zahradnike future, preventive testing. Neither conventional serological tumor markers, spanning from carcinoembryonic antigen (CEA) . to prostate-specific antigen (PSA) ., nor the genomic markers . reported in the past 20 yr, have risen to our expectations with regard to early diagnostic or early disease det

Harass

Madrigal

defendant

強化

OPINE

商店街

Neustart des LHC: die Detektorennstitute approx 90 to 95% of all testicular cancers, whereas the incidence of non-germ-cell tumors of testes is usually less than 10% .. The testicular germ-cell tumors include seminoma, embryonal carcinoma, and teratoma with or without malignant transformation, choriocarcinoma, and yolk sac tumor (